Notas del episodio
My guest on the podcast this week is Alex Zhavoronkov, CEO of Insilico Medicine
On a day-to-day basis, Alex is the CEO of Insilico Medicine (www.insilico.com), which is focused exclusively on developing and applying deep learning methods to drug discovery. It’s probably the largest next-gen AI and bioinformatics company in the world, focusing exclusively on aging and age-related diseases.
Alex is also the director of the Biogerontology Research Foundation and the founder of the International Aging Research Portfolio. He heads the laboratory of regenerative medicine at the Center for Pediatric Hem ...